Research study Program year 2021 Source: CMS Open Payments

Ltse

Research payments

$44,773

9 payments

Through program year 2021, $44,773 in research payments was reported against Ltse, across 9 payments, paid by Apellis Pharmaceuticals, Inc..

Paid by: Apellis Pharmaceuticals, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2021	Research	$44,773	9

Breakdown

Who paid Research payments · program year 2021

Apellis Pharmaceuticals, Inc. $44,773 9 payments

Who received the money Research payments · program year 2021

Duke University Organisation paid for research $23,741 2 payments
Lakes Research, LLC Organisation paid for research $7,216 2 payments
Cancer Specialist of North Florida Organisation paid for research $4,492 2 payments
Denver Health Medical Center Teaching hospital · CO $4,060 1 payment
Cleveland Clinic Hospital Teaching hospital · OH $3,915 1 payment
Baptist Cancer Center Organisation paid for research $1,349 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.